omniture

Research Reports for Penny Stock Top Movers: JDS Uniphase, Arch Coal, Cell Therapeutics, SunPower, and Zynga

2012-02-21 21:55 1166

VANCOUVER, British Columbia, February 21, 2012 /PRNewswire-Asia/ -- Pennystocksinsiders.com (PSI) has issued insider trading reports and Equity Research for the following companies: JDS Uniphase (NASDAQ:JDSU), Arch Coal (NYSE:ACI), Cell Therapeutics (NASDAQ:CTIC), SunPower (NASDAQ:SPWR), and Zynga (NASDAQ:ZNGA).

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

JDS Uniphase Corporation (NASDAQ:JDSU): JDS Uniphase Corporation (NASDAQ:JDSU) lately introduced PacketPortal which is a Smart Network Application Platform (SNAP). By the end of last Friday's trading, JDS Uniphase Corporation raised 1.77% to US$14.93. Are insiders starting to take huge profits by selling shares or exercising stock options? Add JDSU into your watch list for insider trade now.

Read Full Report: http://www.Pennystocksinsiders.com/PR/022112B/JDSU/JDSUniphase.pdf

Arch Coal Inc. (NYSE:ACI): Arch Coal Inc. (NYSE:ACI) announced a fourth quarter 2011 net income for about US$70.9 million, compared to a net income of US$47.8 million for the same period in 2010. Arch Coal last Friday slid 0.14% to US$14.19 with light volume traded. There were 6.96 million shares of Arch Coal exchanging hands as compared to its average daily volume of 8.99 million shares. Share prices of Arch Coal have traded as high as US$36.99 per share and as low as US$13.09 in the past 52 weeks. Investors may want to find out how company insiders like Executive Officers and Directors are thinking about the future business prospects of the company. Check this insider trade report for ACI here.

Read Full Report: http://www.Pennystocksinsiders.com/PR/022112B/ACI/ArchCoal.pdf

Cell Therapeutics, Inc. (NASDAQ:CTIC): Abnormal trading volume of Cell Therapeutics, Inc. (NASDAQ:CTIC) was found on February 17 which reached 23.96 million shares, 9 times heavier than usual day trading. The stock soared 21.62% higher, moving up US$0.24 to US$1.35 per share. Cell Therapeutics, Inc. is a biopharmaceutical corporation which involved in developing an integrated portfolio of oncology products targeted at making cancer more treatable. Do you want to know when company insiders will buy their shares? Want to add and monitor this company on an on-going basis? It can be done for free by registering below.

Read Full Report: http://www.Pennystocksinsiders.com/PR/022112B/CTIC/CellTherapeutics.pdf

Today Pennystocksinsiders.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.

SunPower Corporation (NASDAQ:SPWR):
Read Full Report: http://www.Pennystocksinsiders.com/PR/022112B/SPWR/SunPower.pdf

Zynga Inc. (NASDAQ:ZNGA):
Read Full Report: http://www.Pennystocksinsiders.com/PR/022112B/ZNGA/Zynga.pdf

Insider Filing Source Reference: All observations, analysis and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Pennystocksinsiders.com:

Pennystocksinsiders.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:

Please visit Pennystocksinsiders.com/disclaimers/index.php for details.

Source: Pennystocksinsiders.com
collection